191 related articles for article (PubMed ID: 36998225)
21. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
22. Comparison of salvage therapies for isolated para-aortic lymph node recurrence in patients with uterine cervical cancer after definitive treatment.
Kubota H; Tsujino K; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Soejima T; Yamaguchi S; Sasaki R
Radiat Oncol; 2019 Dec; 14(1):236. PubMed ID: 31878944
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of lymph node ratio in stage IIIC cervical cancer patients triaged to primary treatment by radical hysterectomy with systematic pelvic and para-aortic lymphadenectomy.
Aslan K; Meydanli MM; Oz M; Tohma YA; Haberal A; Ayhan A
J Gynecol Oncol; 2020 Jan; 31(1):e1. PubMed ID: 31788991
[TBL] [Abstract][Full Text] [Related]
24. Surgical or imaging lymph node assessment in locally advanced cervical cancer: a systematic review and meta-analysis.
Delara R; Yang J; Buckner-Petty S; Magtibay P; Butler K
J Gynecol Oncol; 2020 Nov; 31(6):e79. PubMed ID: 33078589
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial.
Tangjitgamol S; Tharavichitkul E; Tovanabutra C; Rongsriyam K; Asakij T; Paengchit K; Sukhaboon J; Penpattanagul S; Kridakara A; Hanprasertpong J; Chomprasert K; Wanglikitkoon S; Atjimakul T; Pariyawateekul P; Katanyoo K; Tanprasert P; Janweerachai W; Sangthawan D; Khunnarong J; Chottetanaprasith T; Supawattanabodee B; Lertsanguansinchai P; Srisomboon J; Isaranuwatchai W; Lorvidhaya V
J Gynecol Oncol; 2019 Jul; 30(4):e82. PubMed ID: 31074236
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.
Liu C; Ran X; Wang Z; Zhang K
Chin Clin Oncol; 2023 Aug; 12(4):38. PubMed ID: 37699603
[TBL] [Abstract][Full Text] [Related]
27. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a randomized controlled trial (C-PACC trial).
Qu X; Qiu J; Jiang L; Qi X; Zhang G; Feng W; Wang Y; Teng Y; Wang X; Guo X; Hua K
J Gynecol Oncol; 2023 Mar; 34(2):e13. PubMed ID: 36424705
[TBL] [Abstract][Full Text] [Related]
29. A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial).
Qiu J; Sun S; Liu Q; Fu J; Huang Y; Hua K
J Gynecol Oncol; 2023 Sep; 34(5):e64. PubMed ID: 37350146
[TBL] [Abstract][Full Text] [Related]
30. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
31. Laparoscopic Extraperitoneal Pelvic Lymph Node Debulking in Locally Advanced Cervical Cancer.
Diaz-Feijoo B; Luna-Guibourg R; Cabrera S; Manrique S; Gil-Moreno A
J Minim Invasive Gynecol; 2019 Feb; 26(2):366. PubMed ID: 29783001
[TBL] [Abstract][Full Text] [Related]
32. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
33. Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas.
Querleu D; Dargent D; Ansquer Y; Leblanc E; Narducci F
Cancer; 2000 Apr; 88(8):1883-91. PubMed ID: 10760766
[TBL] [Abstract][Full Text] [Related]
34. Para-aortic plus pelvic lymphadenectomy in locally advanced cervical cancer: A single institutional experience.
Mezquita G; Muruzabal JC; Perez B; Aguirre S; Villafranca E; Jurado M
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():79-83. PubMed ID: 30889424
[TBL] [Abstract][Full Text] [Related]
35. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
[TBL] [Abstract][Full Text] [Related]
36. Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer.
Cho WK; Kim YJ; Kim H; Kim YS; Park W
Jpn J Clin Oncol; 2020 Sep; 50(10):1150-1156. PubMed ID: 32577748
[TBL] [Abstract][Full Text] [Related]
37. Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer.
Munkarah AR; Jhingran A; Iyer RB; Wallace S; Eifel PJ; Gershenson D; Burke TW
Int J Gynecol Cancer; 2002; 12(6):755-9. PubMed ID: 12445255
[TBL] [Abstract][Full Text] [Related]
38. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
39. Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer.
Mayadev J; Zamarin D; Deng W; Lankes H; O'Cearbhaill R; Aghajanian CA; Schilder R
Int J Gynecol Cancer; 2020 May; 30(5):701-704. PubMed ID: 31871115
[TBL] [Abstract][Full Text] [Related]
40. Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients.
Cetina L; Garcia-Arias A; Candelaria M; Cantú D; Rivera L; Coronel J; Bazan-Perkins B; Flores V; Gonzalez A; Dueñas-González A
World J Surg Oncol; 2009 Feb; 7():19. PubMed ID: 19220882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
